AUROBINDO PHARMA
Largecap | BSE
Sector
Theme
Index
Here's the live share price of Aurobindo Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.67₹ 8.70
As on Mar 12, 2026, 4:01 PM IST
Aurobindo Pharma Price Performance
Today's LowToday's High
₹1,290.50₹1,319.60
₹1,313.30
52 Weeks' Low52 Weeks' High
₹994.35₹1,319.60
₹1,313.30
Open Price
₹1,301.20
Prev. Close
₹1,304.60
Volume
79,056
Over the last 5 years, the share price of Aurobindo Pharma has gained 9.14% CAGR. Over the past year, the corresponding return has been 18.65%.
Aurobindo Pharma’s current P/E of 20.53x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Aurobindo Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | 7.14 | 13.46 | 10.02 | 19.98 | 18.65 | 43.08 | 9.14 |
| Sun Pharmaceutical Industries | 2.36 | 6.44 | 1.71 | 12.92 | 8.87 | 24.13 | 24.37 |
| Divi's Laboratories | -1.16 | 1.64 | -2.13 | 4.37 | 11.02 | 31.47 | 12.36 |
| Torrent Pharmaceuticals | 1.98 | 8.77 | 17.16 | 24.48 | 43.38 | 43.34 | 29.23 |
| Dr. Reddy's Laboratories | 0.53 | 3.57 | 3.15 | 0.27 | 19.43 | 14.61 | 8.31 |
| Lupin | 0.97 | 6.55 | 11.39 | 15.29 | 19.84 | 53.25 | 17.55 |
| Cipla | -0.06 | -0.32 | -12.65 | -15.79 | -8.85 | 14.83 | 10.45 |
| Zydus Lifesciences | 0.33 | -0.36 | -1.25 | -12.19 | 3.20 | 25.38 | 15.70 |
| Mankind Pharma | -0.87 | 6.12 | 1.22 | -14.49 | 1.69 | 15.71 | 9.15 |
| Alkem Laboratories | -1.88 | -7.14 | -3.40 | -0.13 | 14.52 | 21.02 | 14.43 |
| Glenmark Pharmaceuticals | 7.10 | 11.10 | 14.49 | 6.07 | 59.05 | 74.46 | 36.39 |
| Biocon | 1.58 | 4.65 | 1.56 | 7.56 | 20.83 | 21.63 | -0.39 |
| Abbott India | -3.33 | -0.04 | -4.59 | -13.85 | -10.56 | 9.70 | 12.79 |
| Laurus Labs | -0.32 | 2.32 | 2.72 | 16.38 | 78.44 | 50.82 | 23.49 |
| GlaxoSmithKline Pharmaceuticals | 1.18 | -5.98 | -3.49 | -9.64 | -6.52 | 24.59 | 11.56 |
| Ipca Laboratories | 3.98 | 5.70 | 6.30 | 18.62 | 18.43 | 25.35 | 9.82 |
| Ajanta Pharma | 4.82 | 7.92 | 17.20 | 20.92 | 22.52 | 36.75 | 20.62 |
| Anthem Biosciences | -3.60 | -8.61 | -8.12 | -22.91 | -12.05 | -4.19 | -2.54 |
| J B Chemicals & Pharmaceuticals | 2.78 | 11.73 | 18.23 | 25.18 | 41.44 | 29.68 | 28.43 |
| Emcure Pharmaceuticals | 4.23 | 3.71 | 5.12 | 12.28 | 63.36 | 3.65 | 2.18 |
Over the last one year, Aurobindo Pharma has gained 18.65% compared to peers like Sun Pharmaceutical Industries (8.87%), Divi's Laboratories (11.02%), Torrent Pharmaceuticals (43.38%). From a 5 year perspective, Aurobindo Pharma has underperformed peers relative to Sun Pharmaceutical Industries (24.37%) and Divi's Laboratories (12.36%).
Aurobindo Pharma Financials
Aurobindo Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,237.07 | 1,266.02 |
| 10 | 1,221.91 | 1,240.53 |
| 20 | 1,190.41 | 1,216.06 |
| 50 | 1,185.06 | 1,194.63 |
| 100 | 1,180.38 | 1,179.31 |
| 200 | 1,144.92 | 1,170.37 |
Aurobindo Pharma Share Holding Pattern
In the latest quarter, Aurobindo Pharma remained same as its previous close in promoter holding, while DII stake increased to 27.69%, FII holding fell to 13.95%, and public shareholding moved up to 6.55% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Aurobindo Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,33,44,745 | 1.75 | 1,611.64 | |
| 65,00,000 | 2.09 | 785.01 | |
| 44,03,987 | 1.51 | 531.87 | |
| 32,30,588 | 0.65 | 390.16 | |
| 27,22,312 | 0.31 | 328.77 | |
| 21,77,529 | 0.93 | 262.98 | |
| 21,55,679 | 3.91 | 260.34 | |
| 18,14,372 | 0.54 | 219.12 | |
| 17,02,630 | 2.61 | 205.63 | |
| 15,70,197 | 0.45 | 189.63 |
* Excluding Index & Arbitrage Funds
Aurobindo Pharma Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Aurobindo Pharma Options
Aurobindo Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Mar 12, 2026, 3:15 PM IST | Aurobindo Pharma - Classification Of Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company As VAI By Th |
| Mar 11, 2026, 6:45 PM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Mar 11, 2026, 6:41 PM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Mar 09, 2026, 8:11 PM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Mar 04, 2026, 5:39 AM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Aurobindo Pharma
Aurobindo Pharma Ltd. is a Public Limited Listed company incorporated on 26/12/1986 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1986PLC015190 and registration number is 015190. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 10933.30 Cr. and Equity Capital is Rs. 58.08 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No.2, Maitri Vihar, Hyderabad Telangana 500038
- Contact
Management
- Mr. M Ramasubramanian KumarNon Exe.Chairman&Ind.Director
- Mr. K Nithyananda ReddyVice Chairman & Mng.Director
- Mr. M Madan Mohan ReddyWhole Time Director
- Mr. P V Ramprasad ReddyNon Executive Director
- Dr. Satakarni MakkapatiNon Executive Director
- Mr. P Sarath Chandra ReddyNon Executive Director
- Mr. Girish P VanvariIndependent Director
- Mr. Santanu MukherjeeIndependent Director
- Dr. Deepali Pant JoshiIndependent Director
FAQs on Aurobindo Pharma Share Price
What is the share price of Aurobindo Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aurobindo Pharma is ₹1,313.30 as on Mar 12, 2026.
What kind of stock is Aurobindo Pharma?
The Aurobindo Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Aurobindo Pharma?
The market cap of Aurobindo Pharma is ₹76,276.68 Cr as on Mar 12, 2026.
What are today's High and Low prices of Aurobindo Pharma?
Today’s highest and lowest price of Aurobindo Pharma are ₹1,319.60 and ₹1,290.50.
What are the 52 Week High and 52 Week Low of Aurobindo Pharma?
The 52-week high/low is the highest and lowest price at which Aurobindo Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Aurobindo Pharma is ₹1,319.60 and 52-week low of Aurobindo Pharma is ₹994.35 as on Mar 12, 2026.
How has the Aurobindo Pharma performed historically in terms of returns?
The Aurobindo Pharma has shown returns of 0.67% over the past day, 13.46% for the past month, 10.02% over 3 months, 18.65% over 1 year, 43.08% across 3 years, and 9.14% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Aurobindo Pharma?
P/E ratio of and PB ratio of Aurobindo Pharma are 20.53 and 2.12 on Mar 12, 2026. While the company gives a dividend yield of 0.00 per annum.
Aurobindo Pharma News
✕
Market Pulse